COVID-19 Oral Antivirals
COVID-19 Oral Antiviral Agents

Released: January 06, 2022

Expiration: January 05, 2023

Renslow Sherer
Renslow Sherer, MD

Activity

Progress
1
Course Completed

In this episode, Renslow Sherer, MD, discusses key data on COVID-19 oral antiviral agents—molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir—for nonhospitalized adults with mild to moderate COVID-19, including:

  • EPIC-HR study of nirmatrelvir (PF-07321332) plus ritonavir
    • Safety data
    • Efficacy data
  • MOVe-OUT study of molnupiravir
    • Safety data
    • Efficacy data
  • Roles in treatment of COVID-19
    • Timing of treatment